Eli Lilly’s new diabetes drug continues to show promise as an obesity treatment


The Eli Lilly logo is shown on one of the company’s offices in San Diego, California, September 17, 2020.
Mike Blake | Reuters

Articles You May Like

Berkshire Hathaway reports operating earnings surge, but posts big investment loss amid market rout
Coinbase shares drop on billion-dollar loss in second quarter and revenue miss
Stocks making the biggest moves premarket: Expedia, Block, Lyft and more
Zoom investor tells startup founders: ‘Forget the past three years’ and accept 50% valuation hit
Stocks making the biggest moves midday: Bed Bath & Beyond, AMC, First Solar, Palantir and more